Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2025-12-26 @ 3:58 AM
NCT ID:
NCT04889118
Group ID:
EG000
Title:
Pembrolizumab+Lenvatinib
Description:
Participants received pembrolizumab 200 mg via intravenous (IV) infusion on Day 1 of each 3-week cycle for up to 35 administrations (up to approximately 2 years) PLUS lenvatinib 20 mg via oral capsule daily for up to at least 2 years.
Deaths Number Affected:
49
Deaths Number At Risk:
None
Serious Number Affected:
14
Serious Number At Risk:
64
Other Number Affected:
64
Other Number At Risk:
64
Study:
NCT04889118
Results Section:
NCT04889118
Adverse Events Module:
NCT04889118